1. Newhouse JP. Medical care costs: how much welfare loss? J Econ Perspect. 1992;6:3–21. [PubMed] 2. Berwick DM. Disseminating innovations in health care. JAMA. 2003;289:1969–1975. [PubMed]
3. Rogers EM. Diffusion of Innovations. 5. New York: Free Press; 2003.
4. Wennberg JE. Understanding variations in healthcare delivery. N Engl J Med. 1999;340:52–53. [PubMed]
5. New Freedom Commission on Mental Health: Achieving the Promise: Transforming Mental Health Care in America: Final Report. U.S. Department of Health and Human Services Publication SMA-03–3832. Rockville, Md, DHHS, 2003
6. U.S. Department of Health and Human Services: Mental Health: A Report of the Surgeon General. Rockville, Md, U.S. Department of Health and Human Services, Substance Abuse and Mental Health Services Administration, Center for Mental Health Services, National Institutes of Health, National Institute of Mental Health, 1999
7. Wang PS, Lane M, Olfson M, Pincus HA, Wells KB, Kessler RC. Twelve-month use of mental health services in the United States. Arch Gen Psychiatry. 2005;62:629–640. [PubMed]
8. Frank R, Glied S. Better But Not Well. Baltimore, Md: Johns Hopkins University Press; 2006.
9. Lehman AF, Steinwachs DM. Co-investigators of the PORT Project: Patterns of usual care for schizophrenia: initial results from the Schizophrenia Patient Outcomes Research Team (PORT) Studies. Schizophr Bull. 1998;24:11–20. [PubMed]
10. Griliches Z. Hybrid corn: an exploration in the economics of technological change. Econometrica. 1957;25:501–522.
11. Havens AE, Rogers E. Adoption of hybrid corn: profitability, and the interaction effect. Rural Sociol. 1961;26:409–414.
12. Greenhalgh T, Robert G, MacFarlane F, Bate P, Kyriakidou O. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q. 2004;82:581–629. [PubMed]
13. Tolbert PS, Zucker LG. Institutional sources of change in the formal structure of organizations: the diffusion of civil service reform 1880–1935. Admin Sci Quarterly. 1983;28:22–39.
14. Coleman JS, Katz E, Menzel H. Medical Innovation: A Diffusion Study. New York: Bobbs-Merrill; 1966.
15. Essock SM, Goldman HH, Van Tosh L, Anthony WA, Appell CR, Bond GR, Dixon L, Dunakin L, Ganju V, Gorman P, Ralph RO, Rapp CA, Teague GB, Drake RE. Evidence-based practice: setting the context and responding to concerns. Psychiatr Clin North Am. 2003;26:919–938. [PubMed] 16. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis. 1985;27:335–371. [PubMed] 17. Jencks SF, Huff ED, Cuerdon T. Change in the quality of care delivered to Medicare beneficiaries 1998–1999 to 2000–2001. JAMA. 2003;289:305–312. [PubMed] 18. Bradley EH, Holmboe ES, Mattera JA, Roumanis SA, Radford MJ, Krumholz HM. A qualitative study of increasing β-blocker use after myocardial infarction: why do some hospitals succeed? JAMA. 2001;285:2604–2611. [PubMed] 19. Pettinati HM, O’Brien CP, Rabinowitz AR, Wortman SM, Oslin DW, Kampman KM, Dackis CA. The status of nal-trexone in the treatment of alcohol dependence: specific effects on heavy drinking. J Clin Psychopharm. 2006;26:610–625. [PubMed] 20. Ducharme LJ, Knudsen HK, Roman PM. Trends in the adoption of medications for alcohol dependence. J Clin Psychopharm. 2006;26:S13–S19. [PubMed] 21. Grant BF. Prevalence and correlates of drug use and DSM-IV drug dependence in the United States: results of the national longitudinal alcohol epidemiologic survey. J Subst Abuse Treat. 1996;8:195–210. [PubMed] 23. Mark TL, Kranzler HR, Poole VH, Hagen CA, McLeod C, Crosse S. Barriers to the use of medications to treat alcoholism. Am J Addict. 2003;12:281–294. [PubMed]
24. Henggeler SW, Schoenwald SK, Borduin CM, Rowland MD, Cunningham PB. Multisystemic Treatment of Antisocial Behavior in Children and Adolescents. New York: Guilford; 1998.
25. Schoenwald SK. Toward evidence-based transport of evidence-based treatments: MST as an example. J Child Adolesc Subst Abuse Treat. (in press)
26. Henggeler SW, Melton GB, Smith LA. Family preservation using multisystemic therapy: an effective alternative to incarcerating serious juvenile offenders. J Consult Clin Psychol. 1992;60:953–961. [PubMed]
27. Henggeler SW, Melton GB, Smith LA, Schoenwald SK, Hanley J. Family preservation using multisystemic therapy: long-term follow-up to a clinical trial with serious juvenile offenders. J Child Family Studies. 1993;2:283–293.
28. Unützer J, Katon W, Williams JW, Callahan CM, Harpole L, Hunkeler EM, Hoffing M, Arean P, Hegel MT, Schoenbaum M, Oishi SM, Langston CA. Improving primary care for depression in late life: the design of a multicenter randomized trial. Med Care. 2001;39:785–799. [PubMed] 29. Unützer J, Katon W, Callahan CM, Williams JW, Hunkeler E, Harpole L, Hoffing M, Della Penna RD, Noel PH, Lin EH, Arean PA, Hegel MT, Tang L, Belin TR, Oishi S, Langston Collaborative care management of late-life depression in the primary care setting. JAMA. 2002;288:2836–2845. [PubMed] 30. Katon W, Robinson P, VonKorff M, Lin E, Bush T, Ludman E, Simon G, Walker CA. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 2005;53:924–932. [PubMed] 31. Grypma L, Haverkamp R, Little S, Unutzer J. Taking an evidence-based model of depression care from research to practice: making lemonade out of depression. Gen Hosp Psychiatry. 2006;28:101–107. [PubMed] 32. Unützer J, Powers D, Katon W, Langston C. From establishing an evidence-based practice to implementation in real-world settings: IMPACT as a case study. Psychiatr Clin North Am. 2005;28:1079–1092. [PubMed] 33. Scheffler RM, Adams N. Millionaires and mental health: Proposition 63 in California. Health Affairs. 2005;W5:212–224. [PubMed] 34. Lehman AF, Kreyenbuhl J, Buchanan RW, Dickerson FB, Dixon LB, Goldberg R, Green-Paden LD, Tenhula WN, Boerescu D, Tek C, Sandson N, Steinwachs DM. The schizophrenia patient outcomes research team (PORT): updated treatment recommendation 2003. Schizophr Bull. 2004;30:193–217. [PubMed] 35. Lehman AF, Steinwachs DM. the Co-Investigators of the PORT Project. Translating research into practice: the schizophrenia Patient Outcomes Research Team (PORT) treatment recommendations. Schizophr Bull. 1998;24:1–10. [PubMed] 36. Davis JM, Chen N, Glick ID. A meta-analysis of the efficacy of second-generation antipsychotics. Arch Gen Psychiatry. 2003;60:553–564. [PubMed] 38. Owens DC. What CATIE did: some thoughts on implications deep and wide. Psychiatr Serv. 2008;59:530–533. [PubMed] 39. Rosenheck RA, Leslie DL, Doshi JA. Second-generation antipsychotics: cost-effectiveness, policy options, and political decision making. Psychiatr Serv. 2008;59:515–520. [PubMed] 40. Jones PB, Barnes TRE, Davies L, Dunn G, Lloyd H, Hayhurst KP, Murray RM, Markwick A, Lewis SW. Randomized controlled trial of the effect on quality of life of second-vs-first-generation antipsychotic drugs in schizophrenia. Arch Gen Psychiatry. 2006;63:1079–1087. [PubMed] 41. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe SE, Davis SM, Davis CE, Le-bowitz BD, Severe J, Hsiao JK. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2006;353:1209–1223. [PubMed] 42. Marder SR, Essock SM, Miller AL, Buchanan RW, Casey DE, Davis JM, Kane JM, Lieberman JA, Schooler NR, Covell NR, Stroup S, Weissman EM, Wirshing DA, Hall CS, Pogach L, Pi-Sunyer X, Bigger JT, Jr, Friedman A, Kleinberg D, Tevich SJ, Davis B, Shon S. Physical health monitoring of patients with schizophrenia. Am J Psychiatry. 2004;161:1334–1349. [PubMed] 43. McEvoy JP, Meyer J, Goff D, Nasrallah H, Davis SM, Sullivan L, Meltzer HY, Stroup TS, Lieberman JA. Prevalence of the metabolic syndrome in patients with schizophrenia: results from CATIE and comparison with national estimates from NHANES III. Schizophr Res. 2005;80:19–32. [PubMed] 44. Jackevicius CA, Tu JV, Ross JS, Ko DT, Krumholz HM. Use of ezetimibe in the United States and Canada. N Engl J Med. 2008;358:1819–1828. [PubMed]
45. Wennberg D, editor. Dartmouth Atlas of Cardiovascular Healthcare. Dartmouth Medical School and the American Hospital Association; 2000.
46. Wang PS, Demier O, Kessler RC. Adequacy of treatment for serious mental illness in the United States. Am J Public Health. 2002;92:92–98. [PubMed]
47. Semke J, Perdue S. Regional patterns of service for individuals with severe mental illness. Admin Policy Ment Health Serv Res. 1998;25:541–547.
48. Becker T, Vázquez-Barquero JL. The European perspective of psychiatric reform. Acta Psychiatrica Scandinavica. 2001;104:8–14. [PubMed] 49. Kramer TL, Daniels AS, Zieman GL, Williams C, Dewan NA. Psychiatric practice variations in the diagnosis and treatment of major depression. Psychiatr Serv. 2000;51:336–340. [PubMed] 50. Ashton C. Geographic variations in utilization rates in Veterans Affairs Hospitals and clinics. N Engl J Med. 1999;340:32–39. [PubMed]
51. Wright D, Sathe N, Spagnola K. State estimates of substance use from the 2004–2005 National Surveys on Drug Use and Health: DHHS Publication SMA 07-4235, NSDUH Series H-31. Rockville, Md: Substance Abuse and Mental Health Services Administration, Office of Applied Sciences; 2007.
52. Baer JS, Ball SA, Campbell BK, Miele GM, Schoener EP, Tracy K. Training and fidelity monitoring of behavioral interventions in multi-site addictions research. Drug Alcohol Depend. 2007;87:107–118. [PMC free article] [PubMed] 53. Dietrich AJ, Oxman TE, Williams JW, Schulberg HC, Bruce ML, Lee PW, Barry S, Raue PJ, Lefever JJ, Heo M, Rost K, Kroenkie K, Gerrity M, Nutting PA. Re-engineering systems for the treatment of depression in primary care: cluster randomized controlled trial. Br Med J. 2004;329:602–605. [PMC free article] [PubMed] 54. Dopson S, Fitzgerald L, Ferlie E, Gabby J, Locock L. No magic targets: changing clinical practice to become more evidence based. Manage Rev. 2002;37:35–47. [PubMed]
55. Gotham HJ. Advancing the implementation of evidence-based practices into clinical practice: How do we get there from here? Prof Psycho Res Pract. 2006;37:606–613.
56. Hermann RC. Improving Mental Healthcare: A Guide to Measurement–Based Quality Improvement. Washington, DC: American Psychiatric Press; 2005.
57. McHugo GM, Drake RE, Whitley R, Bond GR, Campbell K, Rapp CA, Goldman HH, Lutz W, Finnerty M. Fidelity outcomes in the National Implementing Evidence-Based Practices Project. Psychiatr Serv. 2007;58:1279–1284. [PubMed] 58. Miller WR, Sorensen JL, Selzer JA, Brigham GS. Disseminating evidence-based practices in substance abuse treatment: a review with suggestions. J Subst Abuse Treat. 2006;3:5–39. [PubMed] 59. Shojania KG, Grimshaw JM. Evidence-based quality improvement: the state of the science. Health Affairs. 2005;2:38–150. [PubMed]
60. Skinner J, Staiger D. In: Technological diffusion from hybrid corn to beta blockers, in Hard-to-Measure Goods and Services: Essays in Honor of Zvi Griliches. Berndt E, Hulten CM, editors. Chicago: University of Chicago Press and NBER; 2007.
61. Putnam R. Bowling Alone: The Collapse and Revival of American Community. New York: Simon & Schuster; 2000.
62. Williams J. Geographic variations in health care utilization: the effects of social capital and self-interest. AARP Working Paper; Washington, DC: 2007.
63. Landon BE, Wilson IB, McInnes K, Landrum MB, Hirschhorn L, Marsden PV, Gustafson D, Cleary PD. Effects of a quality improvement collaborative on the outcome of care of patients with HIV infection: the EQHIV study. Ann Intern Med. 2004;14:87–896. [PubMed]